Latest News
First-Trimester Atherogenic Characteristics Associated With Increased Risk for Hypertension
Dapagliflozin Benefits Patients With Type 2 Diabetes, Multiple Risk Factors
Etelcalcetide May Slow Left Ventricular Hypertrophy in SHPT
CVD Risk Linked to Increase Future Malignancy Risk
B.1.1.7 SARS-CoV-2 Variant More Transmissible, But Not Linked to Illness Severity
Scammers Selling Fake COVID-19 Vaccination Cards
Text Messaging Tracks Use of Postop Opioid Prescriptions
Inflammatory Heart Disease Prevalence in Professional Athletes With Prior COVID-19 Infection
Effects of Leisure Time, Work Activity on CV Events Explored
Fish Consumption Linked to Reduced CV Disease Mortality
Nurse Work Environment Tied to Ischemic Stroke Outcomes
Restrictions on Access to Mifepristone Will Be Lifted During Pandemic
Blood Type and COVID-19 Outcomes: Is There a Link?
Edoxaban Dosing Regimens Evaluated for AF-Related Stroke
Latest Features
-
Intravenous IV Vasodilators Remain the First-Line Therapy of Choice for Severe H-AHF
Researchers review the primary clinical and research questions regarding blood pressure (BP) reduction with vasodilators in the early management of hypertensive acute heart failure (H-AHF). -
Digital Health Information Divide May Put Many Older Adults at a Disadvantage
Computer access to digital health information varies by race and ethnicity, a study found. -
Review: COVID-19 Vasculitis or Novel Vasculitis Mimic?
In this interview, Richard Becker, MD, gives us an insight into COVID-19 vasculitis and its manifestations.
-
Loading...
-
Loading...
